Source comparisons
Approved comparison material connected to this topic. Only stored records are displayed.
Comparison
Minoxidil has dominated the hair loss treatment market for decades, making it the natural benchmark against which GHK-Cu should be measured. Both compounds promote hair growth, but they accomplish this through different…
Source: redfoxpeptides.isComparison
Split-Dose Circadian 2mg (1mg AM, 1mg PM) 7–9 AM, 6–8 PM 24 weeks continuous 17.1% Optimal. Aligns peptide availability with mitotic peaks, sustained follicle copper levels Single Daily Dose 2mg (full dose AM) 7–9 AM on…
Source: realpeptides.coComparison
Age Under 35 35–50 Over 50 Younger follicles retain higher regenerative capacity. Dermal papilla stem cells decline with age Hair Loss Stage Norwood 2–3, Ludwig I Norwood 3–4, Ludwig I–II Norwood 5+, Ludwig III Early-st…
Source: realpeptides.coComparison
Topical serum alone 200–400 mcg/mL Twice daily Minimal regrowth (5–8% density increase at 24 weeks) 50–100 micrometers (epidermis only) Insufficient for most cases. Peptide doesn't reach follicle depth without mechanica…
Source: realpeptides.coComparison
Mechanism Wnt activation, TGF-beta1 suppression, VEGF, DPC survival Potassium channel opening, vasodilation, VEGF 5-alpha reductase inhibition, reduces scalp DHT ~60% FDA-approved for hair Yes (topical) Yes (oral) Topic…
Source: peptidesexplorer.comComparison
The delivery method determines how much GHK-Cu reaches the dermal papilla, which sits 3 to 4 mm below the scalp surface. Penetration to follicle depth is the rate-limiting factor for every protocol.
Source: peptidesexplorer.com